A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

NCT00087711 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1713

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Carcinoma

Interventions

DRUG: pemetrexed
DRUG: gemcitabine
DRUG: cisplatin

Sponsor

Eli Lilly and Company